Avista Healthcare Partners Invests in Organogenesis Holdings’ Series A Convertible Preferred Stock

In The News
November 13, 2024

Ropes & Gray represented Avista Healthcare Partners in the purchase of $130 million of Series A Convertible Preferred Stock from Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. The transaction closed on Nov. 12.

Avista Healthcare Partners is a leading New York-based private equity firm with over $8 billion invested in more than 45 growth-oriented health care businesses globally.

The team was led by capital markets partner Faiza Rahman, M&A partner Jackie Cohen, FDA partner Kellie Combs, health care partner Devin Cohen and tax partner Benjamin Rogers.